Conference Coverage

Advances in ankylosing spondylitis hailed as rheumatology’s story of the year

Publish date: March 9, 2020

 

REPORTING FROM RWCS 2020

Pages

Recommended Reading

PREVENT trial shows benefits of secukinumab for nonradiographic axSpA
MDedge Internal Medicine
FDA announces approval of fifth adalimumab biosimilar, Abrilada
MDedge Internal Medicine
Newer IL-17 inhibitors make their case in phase 3 nonradiographic axial spondyloarthritis trials
MDedge Internal Medicine
Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis
MDedge Internal Medicine
Certolizumab may reduce uveitis flares, axSpA disease activity
MDedge Internal Medicine
FDA approves infliximab-axxq for numerous indications
MDedge Internal Medicine
Repeat LTBI testing best in patients taking biologics with new risk factors
MDedge Internal Medicine
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
MDedge Internal Medicine
Meta-analysis highlights safety concerns with interleukin inhibition
MDedge Internal Medicine
HLA-B27 status predicts radiographic phenotype of axSpA
MDedge Internal Medicine